Proceeding and Voting Results of the 36th Annual General Meeting (AGM) of Ganga Pharmaceuticals Limited (the Company) held on Saturday, September 20, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ganga Pharmaceuticals held its 36th AGM on September 20, 2025 at its registered office in Virar (E), Palghar, from 12:00 noon to 12:35 p.m. All four resolutions were passed with 100% votes in favour and zero votes against. The resolutions covered: (1) adoption of the audited financial statements for FY ended March 31, 2025; (2) re-appointment of Mrs. Srijna Sharma as Director (retiring by rotation); (3) appointment of Mr. Munna Baijnath Chaurasia as Independent Director; and (4) appointment of Mr. Aman Mukesh Chaudhari as Independent Director. A total of 31,93,660 shares (54.02% of the 59,11,500 outstanding shares) were voted, with promoters turning out 100% (30,09,500 shares) and only about 6.34% of public shareholders participating. The auditor's report had no qualifications.
A routine, smooth AGM with no surprises — all resolutions passed unanimously. The addition of two new independent directors strengthens board composition, but no material impact on share price is expected from this filing.